News Quantified

INDP – indaptus therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Indaptus Therapeutics (NASDAQ:INDP) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Form 8-K Indaptus Therapeutics, For: Mar 18

Form SCHEDULE 13D/A Indaptus Therapeutics, Filed by: Lazar David E.

Form 4 Indaptus Therapeutics, For: Mar 23 Filed by: Lazar David E.

Form 10-K Indaptus Therapeutics, For: Dec 31

Form SCHEDULE 13D Indaptus Therapeutics, Filed by: Lazar David E.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}